Literature DB >> 12845200

Transsphenoidal microsurgery for pediatric craniopharyngioma: special considerations regarding indications and method.

So-Hyang Im1, Kyu-Chang Wang, Seung-Ki Kim, You-Nam Chung, Hee-Soo Kim, Chul-Hee Lee, Byung-Kyu Cho.   

Abstract

Although the transsphenoidal approach offers a narrow operative field and poor visual control through a small sellar opening, this approach has the advantage of being associated with minimal surgical trauma, especially in children. We share our experience of good surgical outcome achieved by the transsphenoidal approach in selected craniopharyngiomas in childhood, and report on our pediatric series of transsphenoidal complete removals of six relatively large craniopharyngiomas and one Rathke's cleft cyst. The most common presenting symptom was visual dysfunction (6/7). All tumors were 'prechiasmatic' cystic masses with moderate to marked suprasellar extensions and elevated diaphragm sellae. The tumors measured from 25 to 37 mm in maximum diameter in the midsagittal plane (median 33 mm). In 5 of the 7 tumors, the suprasellar portion (range 11-27 mm) was larger than the intrasellar portion (range 8-14 mm). Gross total resection was achieved in all patients. Special attention should be paid to multicystic craniopharyngiomas to prevent the possibility of incomplete tumor resection. The 'bone in a fat pocket' method was useful for preventing postoperative cerebrospinal fluid leakage. Vision was improved in all six patients who had preoperative visual disturbances. Hypopituitarism was provoked by radical tumor removal in all patients and managed by hormonal supplementation therapy. Transsphenoidal surgery is an appropriate approach for the radical excision of intrasellar-suprasellar 'prechiasmatic' craniopharyngiomas, even in children, and even if the tumor has a relatively large suprasellar component. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12845200     DOI: 10.1159/000071321

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  8 in total

1.  Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.

Authors:  M Caldarelli; L Massimi; G Tamburrini; M Cappa; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2005-07-02       Impact factor: 1.475

2.  Visual Outcomes after Endoscopic Endonasal Approach for Craniopharyngioma: The Pittsburgh Experience.

Authors:  S Tonya Stefko; Carl Snyderman; Juan Fernandez-Miranda; Elizabeth Tyler-Kabara; Eric Wang; Lance Bodily; Richard A Bilonick; Paul A Gardner
Journal:  J Neurol Surg B Skull Base       Date:  2016-02-09

3.  Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital.

Authors:  Tadanori Tomita; Robin M Bowman
Journal:  Childs Nerv Syst       Date:  2005-07-26       Impact factor: 1.475

4.  Craniopharyngiomas in children: Turkey experience.

Authors:  Yusuf Erşahin; Taskin Yurtseven; Erkin Ozgiray; Saffet Mutluer
Journal:  Childs Nerv Syst       Date:  2005-07-07       Impact factor: 1.475

Review 5.  Origin of craniopharyngiomas: implication on the growth pattern.

Authors:  Kyu-Chang Wang; Seok Ho Hong; Seung-Ki Kim; Byung-Kyu Cho
Journal:  Childs Nerv Syst       Date:  2005-07-30       Impact factor: 1.475

6.  Suprasellar pediatric craniopharyngioma resection via endonasal endoscopic approach.

Authors:  Zarina S Ali; Shih-Shan Lang; Ameet R Kamat; Nithin D Adappa; James N Palmer; Phillip B Storm; John Y K Lee
Journal:  Childs Nerv Syst       Date:  2013-05-24       Impact factor: 1.475

Review 7.  A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma.

Authors:  Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta
Journal:  Childs Nerv Syst       Date:  2012-10-23       Impact factor: 1.475

8.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.